Status:
UNKNOWN
Chronic Pain, Opioids, and Anger Treatment
Lead Sponsor:
The University of Texas at San Antonio
Conditions:
Anger
Opioid Use
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The current US opioid epidemic is a pressing public health concern. Links between opioid misuse and mortality are well-known; nearly 70% of all drug overdose deaths in 2017 were attributable to opioid...
Detailed Description
Participants will be recruited by electronic announcements and IRB approved recruitment flyers in local pain clinics and pain support groups. These ads and flyers will contain relevant info (e.g., stu...
Eligibility Criteria
Inclusion
- taking opioid pain relievers for at least 3 months in the past 12 months
- maladaptive levels of anger as measured by STAXI-2
- without psychiatric co-morbidity (e.g., major depression, substance use disorder, etc.)
- not undergoing current psychological/psychiatric treatment
- speak English.
Exclusion
- \-
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04438746
Start Date
July 1 2020
End Date
January 1 2023
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas at San Antonio
San Antonio, Texas, United States, 78249